Hypersensitivity reactions, skin irritation, erythema, pruritus, contact dermatitis, urticaria, blister. Rarely, burning sensation, severe skin reactions, nail disorder (e.g. nail discolouration, onychoclasis, onychorrhexis)
Pregnancy Category
Name :
Not Classified
Description
FDA has not yet classified the drug into a specified pregnancy category.
Mode of Action
Amorolfine, a morpholine derivative, is highly active in vitro against numerous pathogenic and opportunistic fungi. It alters fungal cell membranes by interfering w/ sterol biosynthesis.
Interaction
N/A
Pregnancy Category Note
N/A
Adult Dose
Topical/Cutaneous
Skin fungal infections
Adult: As 0.25% cream: Apply once daily for at least 2-3 weeks (up to 6 weeks for foot infections).
Continue for 3-5 days after cure is attained.
Nail fungal infections
Adult: As 5% lacquer: Paint onto the affected nail 1-2 times weekly after filing and cleansing.
Continue until nail has regenerated and the affected areas are cured.
Treatment duration: Approx 6 months (fingernail) or 9-12 months (toenail).
Child Dose
N/A
Renal Dose
N/A
Administration
N/A
Disclaimer
The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.